Adaptive Biotechnologies Corp Stock Probability of Future Stock Price Finishing Over 20.99
| ADPT Stock | USD 5.73 0.05 0.88% |
Adaptive |
Adaptive Biotechnologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Adaptive Biotechnologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Adaptive Biotechnologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Adaptive Biotechnologies had very high historical volatility over the last 90 days | |
| Adaptive Biotechnologies has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 170.28 M. Net Loss for the year was (225.25 M) with loss before overhead, payroll, taxes, and interest of (13.66 M). | |
| Adaptive Biotechnologies Corp currently holds about 383.74 M in cash with (156.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.69. | |
| Over 94.0% of the company shares are held by institutions such as insurance companies |
Adaptive Biotechnologies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Adaptive Stock often depends not only on the future outlook of the current and potential Adaptive Biotechnologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adaptive Biotechnologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 144.4 M | |
| Cash And Short Term Investments | 346.4 M |
Adaptive Biotechnologies Technical Analysis
Adaptive Biotechnologies' future price can be derived by breaking down and analyzing its technical indicators over time. Adaptive Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Adaptive Biotechnologies Corp. In general, you should focus on analyzing Adaptive Stock price patterns and their correlations with different microeconomic environments and drivers.
Adaptive Biotechnologies Predictive Forecast Models
Adaptive Biotechnologies' time-series forecasting models is one of many Adaptive Biotechnologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Adaptive Biotechnologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Adaptive Biotechnologies
Checking the ongoing alerts about Adaptive Biotechnologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Adaptive Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Adaptive Biotechnologies had very high historical volatility over the last 90 days | |
| Adaptive Biotechnologies has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 170.28 M. Net Loss for the year was (225.25 M) with loss before overhead, payroll, taxes, and interest of (13.66 M). | |
| Adaptive Biotechnologies Corp currently holds about 383.74 M in cash with (156.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.69. | |
| Over 94.0% of the company shares are held by institutions such as insurance companies |
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.